Elevated signals related to receptor tyrosine kinases (RTKs)17, the EMT, and cancer stem cells (CSCs)42 have emerged as 3 major causes of drug resistance in diverse species of cancer cells receiving various kinds of therapies. This evidence concerns the gene NTRK1 and cancer.